AAS
GPCR icon

Ameritas Advisory Services’s Structure Therapeutics GPCR Stock Holding History

Ameritas Advisory Services’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-100
Closed -$2.8K – 1417
2025
Q3 		$2.8K Hold
100
– – ﹤0.01% 1938
2025
Q2 		$2.07K Buy
+100
New +$2.2K ﹤0.01% 2473

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Ameritas Advisory Services's GPCR Position: Q4 2025 in Review

Ameritas Advisory Services sold out of Structure Therapeutics (GPCR) in Q4 2025, closing a stake of 100 shares — an estimated $2.8K sold.

Ameritas Advisory Services first reported a position in GPCR in Q2 2025 and held it in 2 quarters. The position peaked at $2.8K in Q3 2025. 197 funds tracked by Wall St. Rank hold GPCR as of Q4 2025.

  • Ameritas Advisory Services reported no remaining Structure Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Ameritas Advisory Services sold 100 Structure Therapeutics shares in Q4 2025, an estimated $2.8K.
  • Ameritas Advisory Services first reported a position in Structure Therapeutics in Q2 2025 and held it in 2 quarters.
  • Ameritas Advisory Services's Structure Therapeutics position peaked at $2.8K in Q3 2025.
  • 197 funds tracked by Wall St. Rank held Structure Therapeutics as of Q4 2025.

Based on Ameritas Advisory Services's 13F filing for Q4 2025, filed 4 Feb 2026.